LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2
Authors
Keywords
-
Journal
Cancer Biomarkers
Volume 28, Issue 2, Pages 231-246
Publisher
IOS Press
Online
2020-06-03
DOI
10.3233/cbm-191181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Warburg effect and its role in tumourigenesis
- (2019) Maphuti T. Lebelo et al. ARCHIVES OF PHARMACAL RESEARCH
- Emerging roles of long non-coding RNAs in tumor metabolism
- (2018) Hui Sun et al. Journal of Hematology & Oncology
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Erratum: Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia
- (2017) W Zhai et al. ONCOGENE
- Anti-angiogenesis target therapy for advanced osteosarcoma
- (2017) Lu Xie et al. ONCOLOGY REPORTS
- HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression
- (2017) Jian Ma et al. Oncotarget
- The Warburg effect and drug resistance
- (2016) Bhaskar Bhattacharya et al. BRITISH JOURNAL OF PHARMACOLOGY
- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism
- (2016) Zhihong Ai et al. CANCER LETTERS
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells
- (2016) Zhen Wei Zou et al. Oncotarget
- Warburg Effect or Reverse Warburg Effect? A Review of Cancer Metabolism
- (2015) Xiao Dong Xu et al. Oncology Research and Treatment
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN/Akt/HIF-1α signaling pathway
- (2014) FENGLIN CHEN et al. ONCOLOGY REPORTS
- Hexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapy
- (2008) Saroj P. Mathupala et al. SEMINARS IN CANCER BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation